XJPX3951
Market cap121mUSD
Dec 24, Last price
876.00JPY
1D
0.11%
1Q
-4.99%
Jan 2017
-33.16%
Name
Asahi Printing Co Ltd
Chart & Performance
Profile
Asahi Printing Co.,Ltd. engages in the manufacture and sale of printing and packaging materials for the pharmaceutical and cosmetic markets primarily in Japan. The company offers OTC medicine packages, prescription drug packages, pharmaceutical roll labels, instruction leaflets, and cosmetic packages. It also provides packaging machines for blister packaging and liquid filling, banding, pillow packaging, automated packaging, various inspections, and corrugated box packaging for shipping and palletizing. The company was founded in 1872 and is headquartered in Toyama, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
Income | |||||
Revenues | 41,871,488 3.89% | 40,302,830 3.86% | 38,806,512 -3.33% | ||
Cost of revenue | 39,425,020 | 37,689,108 | 36,172,438 | ||
Unusual Expense (Income) | |||||
NOPBT | 2,446,468 | 2,613,722 | 2,634,074 | ||
NOPBT Margin | 5.84% | 6.49% | 6.79% | ||
Operating Taxes | 765,323 | 861,068 | 881,659 | ||
Tax Rate | 31.28% | 32.94% | 33.47% | ||
NOPAT | 1,681,145 | 1,752,654 | 1,752,415 | ||
Net income | 1,627,574 -4.69% | 1,707,679 -3.86% | 1,776,211 8.34% | ||
Dividends | (762,110) | (761,353) | (768,538) | ||
Dividend yield | 3.91% | 4.00% | 4.27% | ||
Proceeds from repurchase of equity | (481,149) | (175,331) | |||
BB yield | 2.47% | 0.97% | |||
Debt | |||||
Debt current | 3,729,031 | 5,569,825 | 8,215,928 | ||
Long-term debt | 19,020,728 | 15,855,021 | 18,691,536 | ||
Deferred revenue | 2,018,177 | 1,943,132 | |||
Other long-term liabilities | 2,137,823 | 57,360 | 37,252 | ||
Net debt | 7,764,875 | 5,128,420 | 6,596,536 | ||
Cash flow | |||||
Cash from operating activities | 3,549,594 | 4,575,072 | 4,573,107 | ||
CAPEX | (2,899,423) | (2,624,270) | (844,822) | ||
Cash from investing activities | (4,958,052) | (2,376,488) | (840,192) | ||
Cash from financing activities | (474,937) | (6,054,222) | 3,454,913 | ||
FCF | (1,464,506) | 1,795,542 | 3,747,240 | ||
Balance | |||||
Cash | 8,944,168 | 10,854,556 | 14,733,717 | ||
Long term investments | 6,040,716 | 5,441,870 | 5,577,211 | ||
Excess cash | 12,891,310 | 14,281,284 | 18,370,602 | ||
Stockholders' equity | 32,091,958 | 31,845,641 | 30,783,029 | ||
Invested Capital | 43,476,280 | 38,872,564 | 38,547,360 | ||
ROIC | 4.08% | 4.53% | 4.42% | ||
ROCE | 4.30% | 4.89% | 4.60% | ||
EV | |||||
Common stock shares outstanding | 21,606 | 21,786 | 21,864 | ||
Price | 903.00 3.44% | 873.00 5.95% | 824.00 -11.87% | ||
Market cap | 19,510,218 2.58% | 19,019,178 5.57% | 18,015,936 -12.98% | ||
EV | 28,394,786 | 24,478,950 | 24,926,539 | ||
EBITDA | 5,209,265 | 5,402,268 | 5,543,614 | ||
EV/EBITDA | 5.45 | 4.53 | 4.50 | ||
Interest | 112,478 | 86,266 | 81,577 | ||
Interest/NOPBT | 4.60% | 3.30% | 3.10% |